Nektar Therapeutics (NKTR) jumped +156.2% today due to positive data for its Phase 2 (REZOLVE-AD) study for Atopic Dermatitis. There are several reasons why NKTR gapped up robustly. First, REZOLVE-AD has major ramification for its lead drug RezPeq (an IL2 T regulatory cell stimulator). That is to say, RezPeg is also being studied for other...
Physician investors, let’s talk stocks. When you hear “stocks,” what comes to mind? Flashing trading screens, technical charts, or maybe the adrenaline rush of day trading? Be honest with yourself: when you’re trading stocks, have you consistently pulled off 20% annual returns over the years? If you’re nodding yes, I’m calling your bluff. But if...
If you’re a doctor aiming for early retirement through biotech investing, let me ask you this: Is short-term trading better than buying and holding for the long term? My experience points to a clear answer. But let me share with you a video on trading. Despite the illusion of sophistication, it’s extremely stressful and can...
Fellow physicians! If you’re dreaming of an early, luxurious retirement—sipping coffee on a beach instead of charting at 2 a.m.—you already know what to invest in is only half the battle. The other half? Knowing what not to touch. One wrong move, and you’re not just out money—you’re set back years, stuck working longer than...
To Physicians and Investors, Biotech investing is not for the faint of heart. The sector’s volatility, driven by market sentiment, regulatory shifts, or macroeconomic events like the tariff concerns earlier this year, can test even the most seasoned investors. In early April, as fears of tariffs roiled the markets, benchmarks like the Dow, S&P 500,...
Ready to supercharge your biotech portfolio? Let’s talk about an important variable of stock picking: Market Cap (MC). If you’re chasing market-beating returns (think way beyond the 8% annual stock market average), understanding MC is crucial for smarter, more strategic biotech investing. Buckle up—this is going to change how you see stocks. Market Cap: The...
To doctors, ready to talk about the dream: retiring early and in luxury. Picture this—sipping a perfectly chilled glass of wine on your private balcony overlooking the Pacific, jetting off to Paris for a spontaneous weekend, or settling into a swanky retirement community where every detail screams elegance. Sounds like the good life, right? But...
Hey Doc, let’s talk biotech stocks. Are you chasing quick profits with short-term trades, or are you playing the long game, holding for years of growth? If you’re leaning toward trading, stick with me—this one’s for you. After 15 years in the life sciences trenches, I’ve learned one truth: biotech investing isn’t about flashy, fast...
Hey Doc, I hope you’re loving this bite-sized dose of Investing For Physicians! In just 5 minutes—whether you’re grabbing coffee before rounds or sneaking a read during lunch—you’re sharpening your unique edge in biotech investing. Your clinical and scientific expertise gives you a head start, but to turn that into investing wins, you need the...
Hey Doc, let’s take a moment to reflect on your years in medicine. Ever had a patient who seemed stable, only to take a sudden turn for the worse despite your best efforts? Investing in stocks can feel eerily similar. You pour hours into researching that “perfect” stock, convinced it’s a winner, only to watch...